Literature DB >> 17576835

Synergistic effect of posaconazole and caspofungin against clinical zygomycetes.

María Guembe, Jesús Guinea, Teresa Peláez, Marta Torres-Narbona, Emilio Bouza.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17576835      PMCID： PMC2043197          DOI： 10.1128/AAC.00595-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  10 in total

1.  Synergy, antagonism, and what the chequerboard puts between them.

Authors:  F C Odds
Journal:  J Antimicrob Chemother       Date:  2003-06-12       Impact factor: 5.790

2.  Combined antifungal treatment of visceral mucormycosis with caspofungin and liposomal amphotericin B.

Authors:  P Voitl; C Scheibenpflug; T Weber; O Janata; A M Rokitansky
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2002-08-15       Impact factor: 3.267

3.  In vitro susceptibilities of zygomycetes to combinations of antimicrobial agents.

Authors:  Eric Dannaoui; Javier Afeltra; Jacques F G M Meis; Paul E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

4.  In vitro interaction of posaconazole and caspofungin against clinical isolates of Candida glabrata.

Authors:  E R Oliveira; A W Fothergill; W R Kirkpatrick; B J Coco; T F Patterson; S W Redding
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

5.  Interaction between posaconazole and caspofungin in concomitant treatment of mice with systemic Aspergillus infection.

Authors:  Anthony Cacciapuoti; Judith Halpern; Cara Mendrick; Christine Norris; Reena Patel; David Loebenberg
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

6.  In vitro activities of amphotericin B, caspofungin, itraconazole, posaconazole, and voriconazole against 45 clinical isolates of zygomycetes: comparison of CLSI M38-A, Sensititre YeastOne, and the Etest.

Authors:  Marta Torres-Narbona; Jesús Guinea; José Martínez-Alarcón; Teresa Peláez; Emilio Bouza
Journal:  Antimicrob Agents Chemother       Date:  2006-12-28       Impact factor: 5.191

Review 7.  Combination treatment of invasive fungal infections.

Authors:  Pranab K Mukherjee; Daniel J Sheehan; Christopher A Hitchcock; Mahmoud A Ghannoum
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

8.  Combination therapy with amphotericin B lipid complex and caspofungin acetate of disseminated zygomycosis in diabetic ketoacidotic mice.

Authors:  Brad Spellberg; Yue Fu; John E Edwards; Ashraf S Ibrahim
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

9.  Caspofungin inhibits Rhizopus oryzae 1,3-beta-D-glucan synthase, lowers burden in brain measured by quantitative PCR, and improves survival at a low but not a high dose during murine disseminated zygomycosis.

Authors:  Ashraf S Ibrahim; Joel C Bowman; Valentina Avanessian; Keturah Brown; Brad Spellberg; John E Edwards; Cameron M Douglas
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

10.  Eradication of invasive mucormycosis--effectiveness of the Echinocandin FK463.

Authors:  Peter Jacobs; Lucille Wood; Andrew Du Toit; Ken Esterhuizen
Journal:  Hematology       Date:  2003-04       Impact factor: 2.269
  10 in total
  13 in total

1.  Clinical pharmacodynamics and pharmacokinetics of the antifungal extended-spectrum triazole posaconazole: an overview.

Authors:  Hans-Peter Lipp
Journal:  Br J Clin Pharmacol       Date:  2010-10       Impact factor: 4.335

2.  In vitro interactions between antifungals and immunosuppressive drugs against zygomycetes.

Authors:  Eric Dannaoui; Patrick Schwarz; Olivier Lortholary
Journal:  Antimicrob Agents Chemother       Date:  2009-05-18       Impact factor: 5.191

3.  Treatment options in emerging mold infections.

Authors:  Patricia Muñoz; Jesús Guinea; Emilio Bouza
Journal:  Curr Infect Dis Rep       Date:  2008-11       Impact factor: 3.725

4.  Drug combinations against Mucor irregularis in vitro.

Authors:  Shuzhen Zhang; Ruoyu Li; Jin Yu
Journal:  Antimicrob Agents Chemother       Date:  2013-04-15       Impact factor: 5.191

5.  The strength of synergistic interaction between posaconazole and caspofungin depends on the underlying azole resistance mechanism of Aspergillus fumigatus.

Authors:  Eleftheria Mavridou; Joseph Meletiadis; Antony Rijs; Johan W Mouton; Paul E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2015-01-12       Impact factor: 5.191

Review 6.  Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species.

Authors:  Marisa Z R Gomes; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

7.  Posaconazole enhances the activity of amphotericin B against hyphae of zygomycetes in vitro.

Authors:  Susanne Perkhofer; Maria Locher; Manuel Cuenca-Estrella; Reinhard Rüchel; Reinhard Würzner; Manfred P Dierich; Cornelia Lass-Flörl
Journal:  Antimicrob Agents Chemother       Date:  2008-05-05       Impact factor: 5.191

8.  Internal transcribed spacer region sequence heterogeneity in Rhizopus microsporus: implications for molecular diagnosis in clinical microbiology laboratories.

Authors:  Patrick C Y Woo; Shui-Yee Leung; Kelvin K W To; Jasper F W Chan; Antonio H Y Ngan; Vincent C C Cheng; Susanna K P Lau; Kwok-Yung Yuen
Journal:  J Clin Microbiol       Date:  2009-11-11       Impact factor: 5.948

9.  Rhizomucor variabilis var. regularior and Hormographiella aspergillata infections in a leukemic bone marrow transplant recipient with refractory neutropenia.

Authors:  Mayssa M Abuali; Roberto Posada; Gustavo Del Toro; Elizabeth Roman; Rama Ramani; Sudha Chaturvedi; Vishnu Chaturvedi; Vincent J LaBombardi
Journal:  J Clin Microbiol       Date:  2009-10-21       Impact factor: 5.948

10.  Outbreak of intestinal infection due to Rhizopus microsporus.

Authors:  Vincent C C Cheng; Jasper F W Chan; Antonio H Y Ngan; Kelvin K W To; S Y Leung; H W Tsoi; W C Yam; Josepha W M Tai; Samson S Y Wong; Herman Tse; Iris W S Li; Susanna K P Lau; Patrick C Y Woo; Anskar Y H Leung; Albert K W Lie; Raymond H S Liang; T L Que; P L Ho; K Y Yuen
Journal:  J Clin Microbiol       Date:  2009-07-29       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.